What Is MOTS-c?
<a href="/compounds/mots-c">MOTS-c</a> is a mitochondrial-derived peptide (MDP) - a 16-amino-acid signaling molecule encoded within the mitochondrial genome. Unlike most peptides used in research, MOTS-c is not synthetic in origin. Your body produces it naturally, primarily in skeletal muscle, and levels decline with age.
First identified by Dr. Changhan David Lee at USC in 2015, MOTS-c has generated significant research interest for its role in metabolic regulation, exercise performance, and cellular aging. It activates AMPK (the same pathway triggered by exercise and metformin), regulates glucose metabolism, and appears to improve insulin sensitivity.
For people interested in metabolic optimization, MOTS-c sits at the intersection of longevity science and performance - a peptide your own mitochondria produce that may enhance how your body processes energy.
How MOTS-c Works: Mechanism of Action
MOTS-c operates through several interconnected pathways:
AMPK Activation. MOTS-c activates AMP-activated protein kinase, the master metabolic switch that coordinates cellular energy balance. AMPK activation triggers downstream effects including enhanced glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. This is the same pathway activated by exercise, fasting, and metformin.
Folate-Methionine Cycle Regulation. MOTS-c inhibits the folate cycle and methionine cycle, redirecting cellular metabolism. This de novo purine biosynthesis inhibition leads to <a href="/compounds/aicar">AICAR</a> accumulation, which further activates AMPK. This mechanism is unique among metabolic peptides.
Nuclear Translocation Under Stress. During metabolic stress (exercise, glucose deprivation), MOTS-c translocates from the mitochondria to the cell nucleus, where it regulates gene expression related to stress adaptation. This mitochondria-to-nucleus signaling represents a novel communication pathway.
Insulin Sensitivity. MOTS-c enhances skeletal muscle glucose uptake independent of insulin signaling, potentially offering benefits for insulin-resistant states. Animal studies show improved glucose tolerance even on high-fat diets.
Research Evidence
Metabolism and Obesity The foundational 2015 study (Lee et al., Cell Metabolism) demonstrated that MOTS-c prevented age-dependent and high-fat-diet-induced insulin resistance in mice. Treated mice showed significantly lower body weight gain, improved glucose tolerance, and enhanced fatty acid metabolism compared to controls.
Exercise Performance A 2020 study from the same lab found that MOTS-c levels increase during exercise in humans, and that higher baseline MOTS-c correlates with better physical performance in older adults. In mice, MOTS-c supplementation improved running endurance and physical capacity, even in aged animals.
Aging and Longevity MOTS-c levels decline significantly with age across multiple studies. Circulating MOTS-c is higher in long-lived populations (centenarians in Japanese cohort studies showed higher levels). The peptide appears to function as a mitochondrial signal that coordinates systemic metabolic adaptation to aging.
Bone Health Emerging research suggests MOTS-c may promote osteoblast differentiation and bone formation through AMPK-dependent pathways, with potential implications for age-related osteoporosis.
MOTS-c vs. Other Metabolic Peptides
MOTS-c vs. <a href="/compounds/aod-9604">AOD-9604</a>. Both target fat metabolism, but through completely different mechanisms. AOD-9604 is a modified fragment of growth hormone that stimulates lipolysis directly. MOTS-c works upstream by activating AMPK and improving overall metabolic efficiency. MOTS-c has broader systemic effects; AOD-9604 is more targeted to fat loss.
MOTS-c vs. <a href="/compounds/5-amino-1mq">5-Amino-1MQ</a>. Both are metabolic peptides, but 5-Amino-1MQ works by inhibiting NNMT (an enzyme linked to fat cell expansion), while MOTS-c activates AMPK signaling. They operate through non-overlapping mechanisms.
MOTS-c vs. <a href="/compounds/semaglutide">Semaglutide</a>/<a href="/compounds/tirzepatide">Tirzepatide</a>. GLP-1 agonists primarily reduce appetite through incretin signaling. MOTS-c does not suppress appetite - it improves how cells process energy. GLP-1 drugs are FDA-approved and available through <a href="/clinics">telehealth clinics</a>; MOTS-c remains a research compound.
Dosage Protocols in Research
Research protocols typically use:
- •Standard research dose: 5 mg subcutaneous injection, 3-5 times per week
- •Loading protocol: Some studies use daily administration for the first 2 weeks, then reduce to 3x/week
- •Cycle length: 8-12 weeks in most published protocols
MOTS-c is administered via subcutaneous injection, typically in the abdominal area. It is reconstituted from lyophilized powder with bacteriostatic water.
Important: These doses reflect published research protocols. MOTS-c is not FDA-approved for any indication. Consult a physician before considering any peptide protocol.
Where to Get MOTS-c
MOTS-c is not currently FDA-approved and is not available through <a href="/clinics">telehealth peptide clinics</a>. It is classified as a research compound.
Research-grade MOTS-c is available from several verified vendors. Pricing typically ranges from $40-80 per 5mg vial. Check the <a href="/compounds/mots-c">MOTS-c compound page</a> for current vendor pricing and price-per-mg comparison across suppliers.
When sourcing MOTS-c, prioritize vendors that provide: - Third-party certificates of analysis (COAs) with HPLC purity verification - Endotoxin testing results - Transparent lab sourcing
See our <a href="/methodology">scoring methodology</a> for how we evaluate vendor quality.
Side Effects and Safety
Published research reports minimal adverse effects. The most commonly noted side effects in research contexts include:
- •Mild injection site reactions (redness, swelling)
- •Transient flushing
- •Occasional headache during initial use
Because MOTS-c is an endogenous peptide (your body produces it naturally), the theoretical safety profile is more favorable than fully synthetic compounds. However, long-term safety data in humans is limited, and no large-scale clinical trials have been completed.
Frequently Asked Questions
Is MOTS-c legal? MOTS-c is legal to purchase for research purposes. It is not FDA-approved for human use and is not scheduled as a controlled substance. It is not available through compounding pharmacies or clinics.
How long does MOTS-c take to work? Research protocols typically show measurable changes in glucose metabolism within 2-4 weeks. Exercise performance improvements may take longer (4-8 weeks based on available data).
Can MOTS-c be stacked with other peptides? Research has not evaluated combination protocols. Some researchers have studied MOTS-c alongside <a href="/compounds/nad-plus">NAD+</a> precursors given their overlapping involvement in mitochondrial function, but formal combination studies are lacking.
Does MOTS-c require cycling? Most research protocols use finite durations (8-12 weeks). Whether continuous use provides sustained benefits or leads to desensitization has not been established.
The Bottom Line
MOTS-c is one of the most scientifically interesting metabolic peptides currently being studied. As a naturally-produced mitochondrial signal that activates AMPK, improves glucose metabolism, and enhances exercise adaptation, it occupies a unique space in the peptide landscape.
The research is promising but still early-stage - mostly animal studies with limited human data. For those interested in metabolic optimization through legal, clinically-supervised routes, <a href="/compounds/semaglutide">semaglutide</a> and <a href="/compounds/tirzepatide">tirzepatide</a> are available through <a href="/clinics">peptide clinics</a> with robust clinical evidence. MOTS-c remains a research compound worth watching as more human data emerges.